The Beginning of the Endemic

This article is brought to you by Equifund Technologies, LLC.

Share on facebook
Share on twitter
Share on linkedin

Just in case you’re sick and tired of hearing about COVID-19 and hoping it will one day be over…

The World Health Organization is now warning “this virus may never go away.”

Strangely enough, this new outlook could give investors the opportunity to get in on what could be a $250 billion per year industry.

Why?

It all has to do with the important difference between an epidemic – an outbreak of disease that spreads quickly and affects many individuals at the same time… and an endemic – an infection within a geographic location that is existing perpetually:

Predictability!

According to a recent interview with Graham Medley, PhD, director of the Centre for the Mathematical Modelling of Infectious Diseases at the London School of Hygiene and Tropical Medicine…

For most people, the difference between epidemic disease and endemic disease is that the risks are unknown for an epidemic disease.

We don’t have this kind of government response to the flu every year.

But that’s because public health officials and governments know the risks of the flu. They can predict its patterns and focus on mitigating its impact through education and vaccines.

Now, to be clear, I’m not an infectious disease expert (nor do I play one on TV)…

But as an investor, there are few words I love to hear more than “predictable.”

If you’ve been paying attention to our editorial this month so far, you know that we are very bullish on Telemedicine and Remote Patient Monitoring (and bullish on the whole biotech sector in general)…

And we’re definitely not the only ones…

According to a recent report by McKinsey & Company: With the acceleration of consumer and provider adoption of telehealth and extension of telehealth beyond virtual urgent care, up to $250 billion of current US healthcare spend could potentially be virtualized”

And perhaps even more important, this sweeping change to the way we “consume” healthcare products could help investors “do good while doing well.”

Here’s why…

For the past 40 years, there’s been a startling trend in the world of healthcare in America.

A massive increase in the number of preventable deaths, thanks to chronic diseases.

Chronic conditions are defined by the Center for Disease Control (CDC) as “conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both.”

According to the CDC, six in ten adults in America have some form of chronic disease, and four in ten adults have two or more chronic conditions.

When we look at the Medicare population, these numbers get even more dramatic: Data from the Centers for Medicare and Medicaid Services (CMS) show that over two-thirds of Medicare beneficiaries have two or more chronic conditions.

It’s the leading cause of death and disability, as well as the leading driver of the nation’s $3.7 trillion in annual health care costs.

This is equivalent to 19.6 percent of the U.S. GDP in 2016—in other words, nearly one-fifth of the U.S. economy…

And the problem is only getting worse!

According to The Alliance for Aging Research – the nation’s leading non-profit organization dedicated to supporting and accelerating the pace of medical discoveries to improve the universal human experience of aging and health…

99% of Medicare spending is on behalf of beneficiaries with at least one chronic condition…

And the more chronic conditions they have, the more expensive they are to care for.

According to the RAND Corporation’s study, “Multiple Chronic Conditions in the United States”…

Those with five or more chronic conditions spend twice as much on average as those with three or four conditions…

And a whopping 14-times more than people with no chronic conditions!

Long story short…

People are living longer, and living sicker…

And the rising costs are driving Medicare into insolvency!

If we don’t do something to get control of chronic disease related expenses, it will not only speed up the likely chance of the Medicare Trust being depleted…

But will continue to deepen the already massive Federal Deficit.

However, Medicare is a “sacred cow” in America. Making budget cuts – or reducing coverage – would be potentially devastating for the tens of millions of people who rely on Medicare for their healthcare.

This means the only plausible option for politicians – and America – to address this crisis?

We must innovate!

And the most predictable way to reduce healthcare costs?

We need to focus on prevention – and better management – of chronic conditions.

Sincerely,

Jake Hoffberg

Jake Hoffberg – Publisher
Equifund

Like this article? Share it with a friend:

Share on facebook
Share on twitter
Share on linkedin

This article is not an Equifund Crowd Funding Portal Inc communication. It is brought to you by Equifund Technologies, LLC.

More Articles:

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:

Advertisement:

Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.

Pre-Investment Agreement

The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO

Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:

    • Received and have reviewed the education materials sent to you.
    • UNDERSTAND; that there are restrictions on your ability to cancel your investment commitment and obtain a return of your investment.
    • KNOW; It may be difficult to resell securities acquired under Regulation Crowdfunding.
    • AGREE; investing in securities offered and sold in reliance on section 4(a)(6) of the Securities Act involves risk. Investors should not invest any funds unless he or she can afford to lose the entire amount of his or her investment. Your investment may not work out, and you must be in a financial condition to bear the loss.
  • Hidden
  • Hidden
  • Hidden
  • Hidden

We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.

Complete Your Registration

By verifying your account you agree with our terms of use, privacy policy and pre-dispute arbitration agreement. Please complete the registration process by clicking the link below:

Verify Your Email

Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.

If you have not received the email in 5 minutes, please click here to have it resent.

Questions? Our customer service team is always here to help – 1-866-338-3004

Enter your email address to get instant access to the video: